Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study

Br J Dermatol. 2007 Jan;156(1):191-2. doi: 10.1111/j.1365-2133.2006.07595.x.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Clobetasol / adverse effects
  • Clobetasol / therapeutic use*
  • Double-Blind Method
  • Facial Dermatoses / drug therapy*
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Lupus Erythematosus, Cutaneous / drug therapy*
  • Male
  • Ointments
  • Tacrolimus / adverse effects
  • Tacrolimus / therapeutic use*
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Ointments
  • Clobetasol
  • Tacrolimus